MJP Similarly have been buying regularly for 7 plus years and have never sold and dont intend to. Re the value at the end of the year the Immupel technology must surely be worth more than 2 cents on its own even if Parkinson application was not succesful. So I see far less down side risk.... but the potential upside ......pick your number.!!
Hope to hear that phase 3 6 patients given go ahead imminently by Medical board and agree NZ Trader it would be timely to get an update on the original 4 trial patients and of course to hear from Carol again would be terrific . However I also would understand why she may not want herself in public domain again.
Pretty exciting this next set of 6 patients with 4 of them receiving a triple dose and to both sides of the rain. Appreciate more may not always be better but the results will be intriuging.!
- Forums
- ASX - By Stock
- Final, Group 3, Phase II Trials
MJP Similarly have been buying regularly for 7 plus years and...
-
- There are more pages in this discussion • 135 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 1AI (ASX) to my watchlist
|
|||||
Last
0.8¢ |
Change
-0.001(11.1%) |
Mkt cap ! $13.49M |
Open | High | Low | Value | Volume |
0.9¢ | 0.9¢ | 0.8¢ | $2.312K | 288.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 262203 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 1209087 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 262203 | 0.008 |
13 | 4969787 | 0.007 |
12 | 5426749 | 0.006 |
6 | 2510009 | 0.005 |
4 | 4065000 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 1209087 | 10 |
0.010 | 3949573 | 9 |
0.011 | 1490400 | 3 |
0.012 | 816363 | 4 |
0.014 | 1016153 | 4 |
Last trade - 10.51am 28/08/2024 (20 minute delay) ? |
Featured News
1AI (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online